Rod Sinclair MBBS, MD, FACD
Rod Sinclair MBBS, MD, FACD
Professor Medicine (Dermatology) University of Melbourne, Epworth Hospital and Sinclair Dermatology
Verified email at - Homepage
TitleCited byYear
Secukinumab in plaque psoriasis—results of two phase 3 trials
RG Langley, BE Elewski, M Lebwohl, K Reich, CEM Griffiths, K Papp, ...
New England Journal of Medicine 371 (4), 326-338, 2014
Diseases of the Hair and Scalp
RPR Dawber, RPR Dawber
Wiley-Blackwell, 1997
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial
R Marks, K Gebauer, S Shumack, M Amies, J Bryden, TL Fox, ML Owens, ...
Journal of the American Academy of Dermatology 44 (5), 807-813, 2001
Summary of North American Hair Research Society (NAHRS)-sponsored workshop on cicatricial alopecia, Duke university medical center, February 10 and 11, 2001
EA Olsen, WF Bergfeld, G Cotsarelis, VH Price, J Shapiro, R Sinclair, ...
Journal of the American Academy of Dermatology 48 (1), 103-110, 2003
Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose and dermal tissue
STF Hsiao, A Asgari, Z Lokmic, R Sinclair, GJ Dusting, SY Lim, RJ Dilley
Stem Cells and Development, 2011
Male pattern androgenetic alopecia
R Sinclair
Bmj 317 (7162), 865-869, 1998
Androgenetic alopecia: pathogenesis and potential for therapy
JA Ellis, R Sinclair, SB Harrap
Expert reviews in molecular medicine 4 (22), 1-11, 2002
Telogen effluvium
S Harrison, R Sinclair
Clinical and Experimental Dermatology: Clinical dermatology 27 (5), 389-395, 2002
Prevalence of male and female pattern hair loss in Maryborough
DCC Gan, RD Sinclair
Journal of Investigative Dermatology Symposium Proceedings 10 (3), 184-189, 2005
Non‐melanoma skin cancer in Australia
M Fransen, A Karahalios, N Sharma, DR English, GG Giles, RD Sinclair
Medical Journal of Australia 197 (10), 565-568, 2012
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
K Reich, KA Papp, A Blauvelt, SK Tyring, R Sinclair, D Thaši, K Nograles, ...
The Lancet 390 (10091), 276-288, 2017
Treatment of female pattern hair loss with oral antiandrogens
R Sinclair, M Wewerinke, D Jolley
British Journal of Dermatology 152 (3), 466-473, 2005
Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis
Y Wen, Y Liu, Y Xu, Y Zhao, R Hua, K Wang, M Sun, Y Li, S Yang, ...
Nature genetics 41 (2), 228, 2009
Rook's textbook of dermatology
C Griffiths, J Barker, T Bleiker, R Chalmers, D Creamer
John Wiley & Sons, 2016
Disorders of hair growth: diagnosis and treatment
EA Olsen
McGraw-Hill, 2003
Female pattern hair loss: current treatment concepts
QQ Dinh, R Sinclair
Clinical interventions in aging 2 (2), 189, 2007
Androgenetic alopecia in men aged 40–69 years: prevalence and risk factors
G Severi, R Sinclair, JL Hopper, DR English, MRE McCredie, P Boyle, ...
British Journal of Dermatology 149 (6), 1207-1213, 2003
Evidence that the bulge region is a site of relative immune privilege in human hair follicles
KC Meyer, JE Klatte, HV Dinh, MJ Harries, K Reithmayer, W Meyer, ...
British Journal of Dermatology 159 (5), 1077-1085, 2008
Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial.
KA Papp, C Reid, P Foley, R Sinclair, DH Salinger, G Williams, H Dong, ...
The Journal of investigative dermatology 132 (10), 2466, 2012
Androgenetic alopecia in men and women
RD Sinclair, RPR Dawber
Clinics in dermatology 19 (2), 167-178, 2001
The system can't perform the operation now. Try again later.
Articles 1–20